Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients

Hypertension

Volumn 31, Issue 4, 1998, Pages 900-905

  Perticone, Francesco ^a   Ceravolo, Roberto ^b   Maio, Raffaele ^b   Ventura, Giorgio ^b   Zingone, Adriana ^b   Perrotti, Nicola ^b   Mattioli, Pier Luigi ^b  

^a Policlinico Mater Domini   (Italy)

^b NONE

Author keywords

Angiotensin converting enzyme; Endothelium; Hypertension, essential; Polymorphism

Indexed keywords

ACETYLCHOLINE; DIPEPTIDYL CARBOXYPEPTIDASE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INTRON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031948810     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.900     Document Type: Article

References (48)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
2. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
3. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
4. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacological and chemical properties identical to those of the nitric oxide radicals. Circ Res. 1987;61:866-879.
5. Myers PR, Minor RL Jr, Guerra R Sr, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble s-nitrosocysteine than nitric oxide. Nature. 1990;345:161-163.
6. Smith RP, Kruszyna H. Nitroprusside produces cyanide poisoning via reaction with hemoglobin. J Pharmacol Exp Ther. 1974;191:557-563.
7. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
8. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
9. Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res. 1988;62:185-190.
10. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
11. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
12. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
13. Zeither AM, Drexler H, Saubier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolaemia, and hypertension. J Clin Invest. 1993;92: 652-662.
14. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430-1432.
15. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
16. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J. 1995;74: 584-591.
17. Pujia A, Gnasso A, Irace A, Dominijanni A, Zingone A, Perrotti N, Colonna A, Mattioli PL. Association between ACE D/D polymorphism and hypertension in type II diabetic subjects. J Hum Hypertens. 1994;8:687-691.
18. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 1988; 85:9386-9390.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
20. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
21. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor tor myocardial infarction. Nature. 1992;359: 641-644.
22. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993;342:1073-1075.
23. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993;342:1085-1086.
24. Schunkert H, Hense H-V, Holmer SR. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
25. Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A, Malatesta P, Perrotti N, Tramontano D, Mattioli PL. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol. 1997;29:365-369.
26. Liz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol. 1993; 22(suppl 9):S1-S8.
27. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Tekeshita A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20:175-180.
28. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499-505.
29. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene. Nucleic Acid Res. 1992;20:1433.
30. Shanmugam V, Sell KW, Saha BK. Mistyping ACE Heterozygotes. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1993;120-121.
31. Clark S, Fowlies S, Coats A, Radaelli A, Van der Putt M, Bird R, Conway J. Ambulatory blood pressure monitoring: validation of the TM-2420 according to the AAMI recommendation. J Hum Hypertens. 1991;5:77-82.
32. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, Hunter A. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens. 1991;4:890-896.
33. Whitney RJ. Measurement of changes in human limb volume by means of a mercury-in-rubber strain gauge. J Physiol. 1948;109:5P-6P.
34. Greenfield ADM, Whitney RJ, Mowbray JF. Methods for the investigation of peripheral blood flow. Br Med Bull. 1963;19:101-109.
35. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25-29.
36. Kerslake DM. The effect of application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol. 1949;108: 451-457.
37. 2-adrenoceptor stimulation in patients with congestive heart failure. Circulation. 1994;90:17-22.
38. Indolfi C, Piscione F, Ceravolo R, Maione AG, Focaccio A, Rao MA, Esposito G, Condorelli M, Chiariello M. Limb vasoconstriction after successful angioplasty of the left anterior descending coronary artery. Circulation. 1995;92:2109-2112.
39. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990.
40. Lüscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension. 1987;9:157-163.
41. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21: 1145-1151.
42. Taddei S, Virdis A, Mattei P, Arzilli F, Salvetti A. Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension. J Cardiovasc Pharmacol. 1992;20: S193-S195.
43. Lüscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension. 1987;2(suppl III):III-193-III-197.
44. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension. 1986;8(suppl II): II-61-II-66.
45. Vanhoutte PM. Endothelium and control of vascular function: state of the art lecture. Hypertension. 1989;13:658-667.
46. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
47. Celermajer DS, Sorensen KE, Barley J, Jeffrey S, Carter N. Deanfield J. Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis. 1994;111:121-126.
48. Berkenboom G, Brekine D, Unger T, Grosfils K, Staroukine M, Fontaine J. Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta. Hypertension. 1995;26:738-743.